Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-040412
Filing Date
2008-02-28
Accepted
2008-02-27 20:25:59
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1800720
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT dex1020.htm EX-10.20 88291
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2290
4 CERTIFICATE OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9098
5 CERTIFICATE OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9156
6 CERTIFICATE OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3112
7 CERTIFICATE OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3091
8 GRAPHIC g54558g00i92.jpg GRAPHIC 28257
  Complete submission text file 0001193125-08-040412.txt   1956227
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Filer) CIK: 0000921506 (see all company filings)

EIN.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21643 | Film No.: 08648231
SIC: 2836 Biological Products, (No Diagnostic Substances)